Variant report
Variant | esv2755383 |
---|---|
Chromosome Location | chr2:123915791-123928492 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MKI67IP-12 | chr2:123917312-123917526 | NONHSAT074095 |
2 | lnc-MKI67IP-12 | chr2:123918438-123918491 | NONHSAT074095 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142570527 | chr2:123917327-123917328 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs568913416 | chr2:123917335-123917336 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs187979257 | chr2:123917350-123917351 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs540308475 | chr2:123917405-123917406 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs554588068 | chr2:123917438-123917439 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs554664886 | chr2:123917446-123917447 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs576312411 | chr2:123917455-123917456 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs560249520 | chr2:123917469-123917470 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs540040873 | chr2:123917496-123917497 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs553646942 | chr2:123917498-123917499 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs185074392 | chr2:123918472-123918473 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs535735085 | chr2:123918600-123918601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547110279 | chr2:123918610-123918611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570275916 | chr2:123918611-123918612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs140453921 | chr2:123918631-123918632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs556182703 | chr2:123918635-123918636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs17009469 | chr2:123918648-123918649 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs535468965 | chr2:123918681-123918682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs555761305 | chr2:123918728-123918729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs146489217 | chr2:123918729-123918730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541504232 | chr2:123918786-123918787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs76555815 | chr2:123918833-123918834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs578182250 | chr2:123918839-123918840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs143721678 | chr2:123918894-123918895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs563818452 | chr2:123918914-123918915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs80036125 | chr2:123918931-123918932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547851453 | chr2:123918950-123918951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577011682 | chr2:123918951-123918952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73951664 | chr2:123918989-123918990 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs547044557 | chr2:123918997-123918998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs541131036 | chr2:123918998-123918999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs79784263 | chr2:123919005-123919006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs79990356 | chr2:123919032-123919033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs377048309 | chr2:123919061-123919062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs140983474 | chr2:123919067-123919068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs185348367 | chr2:123919094-123919095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs192171432 | chr2:123919133-123919134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs555392335 | chr2:123919142-123919143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs12616531 | chr2:123919143-123919144 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs184604600 | chr2:123919151-123919152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs189345971 | chr2:123919154-123919155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs578173123 | chr2:123919210-123919211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs577221024 | chr2:123919252-123919253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs543638906 | chr2:123919269-123919270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs180706497 | chr2:123919337-123919338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs114641683 | chr2:123919359-123919360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs115621502 | chr2:123919367-123919368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs146451555 | chr2:123919391-123919392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs981552 | chr2:123920838-123920839 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs139052413 | chr2:123920842-123920843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Mental retardation | 17621639 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neurocytoma | 17123091 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Developmental delay | 21147756 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Bladder cancer | 21909424 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:123918600-123919200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr2:123918600-123919200 | Enhancers | Fetal Lung | lung |
3 | chr2:123918600-123919400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr2:123918800-123919200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr2:123919000-123919400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr2:123919000-123919400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr2:123920800-123921800 | Enhancers | Fetal Stomach | stomach |
8 | chr2:123921000-123922600 | Enhancers | Brain Germinal Matrix | brain |
9 | chr2:123921800-123922200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |